Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Zhejiang Lifeng Pharmaceutical is a prominent Chinese pharmaceutical company specializing in the research, development, and large-scale manufacture of Active Pharmaceutical Ingredients (APIs) and chemical intermediates. Founded in 1995 and headquartered in Linhai, Zhejiang, the company has established itself as a leading global supplier of neurological and antiepileptic medications. Its core product portfolio includes high-demand APIs such as Gabapentin, Pregabalin, and various Valproic Acid derivatives. Lifeng operates advanced manufacturing facilities that adhere to stringent international quality standards, maintaining certifications from the US FDA and European regulatory agencies. The company serves as a critical partner in the global pharmaceutical supply chain, providing chemical synthesis and contract manufacturing services to both generic and innovative pharmaceutical firms.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on LI FENG.